Pediatric Cough/Cold OTC Safety Review Continues With Joint Panel Planned

FDA does not go far enough with its recent public health advisory on pediatric cough/cold OTCs to address the potential severe adverse events described in a citizen petition recommending labeling changes to the products, according to one of the petitioners

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet